Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Phase II Trial of Cabozantinib (XL-184) (NSC #761968) in Women with Recurrent, Clear Cell Carcinoma of the Ovary, Fallopian Tube, or Peritoneum (NRG)
IRB NRG-GY001
CC 15-684
Hospital Fairview, Hillcrest, Main Campus
Phase Phase 2
Disease Gynecologic
Drug Cabozantinib
